We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
- Authors
Sutcliffe, Siobhan; Grubb Iii, Robert L; Platz, Elizabeth A; Ragard, Lawrence R; Riley, Thomas L; Kazin, Sally S; Hayes, Richard B; Hsing, Ann W; Andriole, Gerald L; Urologic Diseases in America Project
- Abstract
Study Type - Therapy (cohort) Level of Evidence 4. What's known on the subject? and What does the study add? Accumulating evidence suggests that inflammation may contribute to the development of BPH and LUTS. Therefore, it is plausible that anti-inflammatory agents, such as aspirin and other NSAIDs, may reduce the risk of BPH/LUTS, as was observed in a recent analysis of daily aspirin use and BPH/LUTS risk in the Olmsted County Study of Urinary Symptoms and Health Status in Men. The present study, conducted in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, found no association for recent aspirin or ibuprofen use with the risk of BPH/LUTS.
- Publication
BJU international, 2012, Vol 110, Issue 7, p1050
- ISSN
1464-410X
- Publication type
Journal Article
- DOI
10.1111/j.1464-410X.2011.10867.x